Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ac 0137
2. Ac 137
3. Lys-cys-asn-thr-ala-thr-cys-ala-thr-gln-arg-leu-ala-asn-phe-leu-val-his-ser-ser-asn-asn-phe-gly-pro-ile-leu-pro-pro-thr-asn-val-gly-ser-asn-thr-tyr-nh2
4. Pramlintide
5. Pramlintide Acetate
6. Tripro-amylin
1. Pramlintide Acetate [usan]
2. Schembl238214
3. Unii-726i6te06g
4. Aco137
5. 726i6te06g
6. 25-l-proline-28-l-proline-29-l-proline-, Acetate (salt), Hydrate
7. 25-l-proline-28-l-proline-29-l-prolineamylin (human) Acetate (salt), Hydrate
Molecular Weight | 3951 g/mol |
---|---|
Molecular Formula | C171H269N51O53S2 |
XLogP3 | -16.7 |
Hydrogen Bond Donor Count | 58 |
Hydrogen Bond Acceptor Count | 59 |
Rotatable Bond Count | 122 |
Exact Mass | 3949.9396798 g/mol |
Monoisotopic Mass | 3948.9363250 g/mol |
Topological Polar Surface Area | 1690 Ų |
Heavy Atom Count | 277 |
Formal Charge | 0 |
Complexity | 9620 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 41 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Symlin |
PubMed Health | Pramlintide (Injection) |
Drug Classes | Antidiabetic |
Active Ingredient | Pramlintide acetate |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | eq 1.5mg base/1.5ml (eq 1mg base/ml); eq 2.7mg base/2.7ml (eq 1mg base/ml) |
Market Status | Prescription |
Company | Astrazeneca Ab |
2 of 2 | |
---|---|
Drug Name | Symlin |
PubMed Health | Pramlintide (Injection) |
Drug Classes | Antidiabetic |
Active Ingredient | Pramlintide acetate |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | eq 1.5mg base/1.5ml (eq 1mg base/ml); eq 2.7mg base/2.7ml (eq 1mg base/ml) |
Market Status | Prescription |
Company | Astrazeneca Ab |
Hypoglycemic Agents
Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
40
PharmaCompass offers a list of Pramlintide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pramlintide manufacturer or Pramlintide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pramlintide manufacturer or Pramlintide supplier.
PharmaCompass also assists you with knowing the Pramlintide API Price utilized in the formulation of products. Pramlintide API Price is not always fixed or binding as the Pramlintide Price is obtained through a variety of data sources. The Pramlintide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Symlin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Symlin, including repackagers and relabelers. The FDA regulates Symlin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Symlin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Symlin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Symlin supplier is an individual or a company that provides Symlin active pharmaceutical ingredient (API) or Symlin finished formulations upon request. The Symlin suppliers may include Symlin API manufacturers, exporters, distributors and traders.
click here to find a list of Symlin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Symlin DMF (Drug Master File) is a document detailing the whole manufacturing process of Symlin active pharmaceutical ingredient (API) in detail. Different forms of Symlin DMFs exist exist since differing nations have different regulations, such as Symlin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Symlin DMF submitted to regulatory agencies in the US is known as a USDMF. Symlin USDMF includes data on Symlin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Symlin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Symlin suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Symlin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Symlin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Symlin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Symlin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Symlin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Symlin suppliers with NDC on PharmaCompass.
Symlin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Symlin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Symlin GMP manufacturer or Symlin GMP API supplier for your needs.
A Symlin CoA (Certificate of Analysis) is a formal document that attests to Symlin's compliance with Symlin specifications and serves as a tool for batch-level quality control.
Symlin CoA mostly includes findings from lab analyses of a specific batch. For each Symlin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Symlin may be tested according to a variety of international standards, such as European Pharmacopoeia (Symlin EP), Symlin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Symlin USP).